259 related articles for article (PubMed ID: 31671186)
1. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
2. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
3. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
4. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey.
Kawatkar AA; Jacobsen SJ; Levy GD; Medhekar SS; Venkatasubramaniam KV; Herrinton LJ
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1649-56. PubMed ID: 22674912
[TBL] [Abstract][Full Text] [Related]
5. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract][Full Text] [Related]
6. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
Targownik LE; Benchimol EI; Witt J; Bernstein CN; Singh H; Lix L; Tennakoon A; Zubieta AA; Coward S; Jones J; Kuenzig E; Murthy SK; Nguyen GC; Peña-Sánchez JN; Kaplan G
Inflamm Bowel Dis; 2019 Sep; 25(10):1718-1728. PubMed ID: 31211836
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of patients with anemia in selected diseases.
Ershler WB; Chen K; Reyes EB; Dubois R
Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
[TBL] [Abstract][Full Text] [Related]
9. Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016.
Singh S; Qian AS; Nguyen NH; Ho SKM; Luo J; Jairath V; Sandborn WJ; Ma C
Inflamm Bowel Dis; 2022 Mar; 28(3):364-372. PubMed ID: 33988697
[TBL] [Abstract][Full Text] [Related]
10. Health care utilization and expenditures among adults with rheumatoid arthritis using specialty pharmaceuticals.
Park T
Res Social Adm Pharm; 2019 Jun; 15(6):724-729. PubMed ID: 30241878
[TBL] [Abstract][Full Text] [Related]
11. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
[TBL] [Abstract][Full Text] [Related]
12. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
13. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system.
Menon J; Mishra P
Osteoarthritis Cartilage; 2018 Apr; 26(4):480-484. PubMed ID: 29269328
[TBL] [Abstract][Full Text] [Related]
14. Variations in care: a retrospective database analysis of healthcare utilization patterns for patients with inflammatory bowel disease.
David G; Gunnarsson C; Lofland JH
J Med Econ; 2015 Feb; 18(2):137-44. PubMed ID: 25335098
[TBL] [Abstract][Full Text] [Related]
15. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
16. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
[TBL] [Abstract][Full Text] [Related]
17. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
18. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
19. Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012.
Tun K; Shurko JF; Ryan L; Lee GC
PLoS One; 2018; 13(11):e0206893. PubMed ID: 30383858
[TBL] [Abstract][Full Text] [Related]
20. Five-year Impact of a Commercial Accountable Care Organization on Health Care Spending, Utilization, and Quality of Care.
Zhang H; Cowling DW; Graham JM; Taylor E
Med Care; 2019 Nov; 57(11):845-854. PubMed ID: 31348124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
